(株)ファンペップの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4881/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/07/01 | 日証協 | 132,000株 | -18.97% | 32,600株 | +8050% | 670,718株 | -2.92% | 478,513株 | +6936.96% |
2022/06/24 | 日証協 | 162,900株 | -0.85% | 400株 | -86.21% | 690,919株 | -1.23% | 6,800株 | +12.83% |
2022/06/17 | 日証協 | 164,300株 | -7.28% | 2,900株 | -65.06% | 699,517株 | -0.83% | 6,027株 | -48.29% |
2022/06/10 | 日証協 | 177,200株 | -0.28% | 8,300株 | +16.9% | 705,351株 | +0.82% | 11,656株 | -30.2% |
2022/06/03 | 日証協 | 177,700株 | +3.86% | 7,100株 | -89.65% | 699,636株 | +1.72% | 16,700株 | +234% |
2022/05/27 | 日証協 | 171,100株 | +0.23% | 68,600株 | +66.91% | 687,836株 | +2.2% | 5,000株 | -76.74% |
2022/05/20 | 日証協 | 170,700株 | -0.76% | 41,100株 | +1184.38% | 673,036株 | -1.33% | 21,500株 | +327.44% |
2022/05/13 | 日証協 | 172,000株 | -35.36% | 3,200株 | +357.14% | 682,136株 | -11.42% | 5,030株 | -67.55% |
2022/05/06 | 日証協 | 266,100株 | +0.08% | 700株 | -97.39% | 770,107株 | +1.74% | 15,500株 | -40.84% |
2022/04/28 | 日証協 | 265,900株 | -5.94% | 26,800株 | +66.46% | 756,907株 | -1.16% | 26,200株 | +79.45% |
2022/04/22 | 日証協 | 282,700株 | +1.47% | 16,100株 | -64.38% | 765,807株 | +0.46% | 14,600株 | -38.91% |
2022/04/15 | 日証協 | 278,600株 | -3.96% | 45,200株 | +5.36% | 762,307株 | -0.21% | 23,900株 | -19.8% |
2022/04/08 | 日証協 | 290,100株 | -8.46% | 42,900株 | +47.42% | 763,907株 | -2.5% | 29,800株 | -51.49% |
2022/04/01 | 日証協 | 316,900株 | -8.62% | 29,100株 | -11.01% | 783,507株 | +2.77% | 61,430株 | -18.32% |
2022/03/25 | 日証協 | 346,800株 | -7.35% | 32,700株 | +3.81% | 762,389株 | -0.42% | 75,212株 | +202.06% |
2022/03/18 | 日証協 | 374,300株 | -10.07% | 31,500株 | -36.62% | 765,577株 | -2.99% | 24,900株 | -30.83% |
2022/03/11 | 日証協 | 416,200株 | +3.53% | 49,700株 | +72.57% | 789,177株 | -1.24% | 36,000株 | +93.55% |
2022/03/04 | 日証協 | 402,000株 | -9.48% | 28,800株 | -49.3% | 799,077株 | -2.7% | 18,600株 | -7.47% |
2022/02/25 | 日証協 | 444,100株 | +3.64% | 56,800株 | +119.31% | 821,277株 | +1.07% | 20,102株 | +26.41% |
※株式分割は考慮していませんのでご注意ください。
Page Top